Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
carboplatin (paraplatin) (2 trials)
fluorouracil (efudex) (2 trials)
nitrous oxide (1 trial)
oxygen (1 trial)
capecitabine (xeloda) (1 trial)
cetuximab (erbitux) (1 trial)
hydroxyurea (hydrea) (1 trial)
paclitaxel (taxol) (1 trial)
Adenocarcinoma (Phase 2)
Colorectal Neoplasms (Phase 2)
Esophageal Neoplasms (Phase 2)
Head and Neck Neoplasms (Phase 3)
Hematologic Neoplasms (Phase 3)
Neoplasm Metastasis (Phase 3)
Trials (6 total)
Trial APIs (8 total)